We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine ...

It's not a just a revolutionary and safe vaccine technology – mRNA could help make the best and most expensive drugs in the ...

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the COVID pandemic and has shown promise in addressing a ran ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

Researchers found antibodies in those who reported the most positive moods were 16% higher when compared to those with lowest ...

Not just IgG4 antibodies that become predominant in the many-jabbed, but also lesser studied IgG2, researchers find. NIH ...

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

Total company revenue fell from a peak of $19.3 billion in 2022 to $3.2 billion for the full year ended Dec. 31, 2024. For ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...